BeiGene Ltd - ADR (BGNE) Dividend History
BeiGene Ltd is a clinical-stage biopharmaceutical company engaged in the discovery & development of molecularly targeted & immuno-oncology drugs for the treatment of cancer. Its product includes BGB-3111, BGB-283 and BGB-290 and one immuno-oncology agent.
Last update 12/11/2023
Dividend Yield Summary
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
| Dividends | - | - | - | - | - | - |
| Average Price | 140.32 | 208.18 | 331.75 | 180.92 | 215.47 | - |
| Yield | - | - | - | - | - | - |
Dividend History
No history of dividends
| Date | Amount Per Share | Note |